- Home
- AVIR vs AVNW Comparison
AVIR vs AVNW Comparison
Compare AVIR & AVNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVIR
- AVNW
- Stock Information
- Founded
- AVIR 2012
- AVNW 2006
- Country
- AVIR United States
- AVNW United States
- Employees
- AVIR N/A
- AVNW N/A
- Industry
- AVIR Medicinal Chemicals and Botanical Products
- AVNW Radio And Television Broadcasting And Communications Equipment
- Sector
- AVIR Health Care
- AVNW Technology
- Exchange
- AVIR Nasdaq
- AVNW Nasdaq
- Market Cap
- AVIR 247.5M
- AVNW 283.7M
- IPO Year
- AVIR 2020
- AVNW 2007
- Fundamental
- Price
- AVIR $3.42
- AVNW $18.08
- Analyst Decision
- AVIR Hold
- AVNW Strong Buy
- Analyst Count
- AVIR 1
- AVNW 5
- Target Price
- AVIR $6.88
- AVNW $38.60
- AVG Volume (30 Days)
- AVIR 556.5K
- AVNW 235.2K
- Earning Date
- AVIR 02-26-2025
- AVNW 02-04-2025
- Dividend Yield
- AVIR N/A
- AVNW N/A
- EPS Growth
- AVIR N/A
- AVNW N/A
- EPS
- AVIR N/A
- AVNW N/A
- Revenue
- AVIR N/A
- AVNW $409,603,000.00
- Revenue This Year
- AVIR N/A
- AVNW $9.06
- Revenue Next Year
- AVIR N/A
- AVNW $7.87
- P/E Ratio
- AVIR N/A
- AVNW N/A
- Revenue Growth
- AVIR N/A
- AVNW 17.00
- 52 Week Low
- AVIR $2.75
- AVNW $12.96
- 52 Week High
- AVIR $4.60
- AVNW $38.85
- Technical
- Relative Strength Index (RSI)
- AVIR 62.36
- AVNW 57.39
- Support Level
- AVIR $3.19
- AVNW $17.15
- Resistance Level
- AVIR $3.32
- AVNW $17.98
- Average True Range (ATR)
- AVIR 0.13
- AVNW 0.85
- MACD
- AVIR 0.04
- AVNW 0.12
- Stochastic Oscillator
- AVIR 82.58
- AVNW 68.11
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About AVNW Aviat Networks Inc.
Aviat Networks Inc is a networking solutions provider. It designs, manufactures, and sells wireless networking products, solutions, and services to mobile and fixed operators, private network operators, government agencies, transportation and utility companies, public safety agencies, and broadcast network operators around the world. The company's product categories include point-to-point microwave and millimeter wave radios that are licensed (subject to local frequency regulatory requirements), lightly licensed and license-exempt (operating in license-exempt frequencies), and element and network management software.